Seres Therapeutics, Inc. (MCRB)
NASDAQ·Healthcare·Biotechnology
$4.75
-1.04%
Mkt Cap $83.09M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$1.25
Range $1.25 – $1.25
Implied Upside
-73.7%
Consensus $1.25 vs current $4.75
NASDAQ·Healthcare·Biotechnology
$4.75
-1.04%
Mkt Cap $83.09M
No recent rating data.
Price Target (1 analysts)
$1.25
Range $1.25 – $1.25
-73.7%
Consensus $1.25 vs current $4.75